Exact Mass: 411.10934060000005

Exact Mass Matches: 411.10934060000005

Found 18 metabolites which its exact mass value is equals to given mass value 411.10934060000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tiagabine hydrochloride

Tiagabine hydrochloride

C20H26ClNO2S2 (411.10934060000005)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D058805 - GABA Uptake Inhibitors C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents D049990 - Membrane Transport Modulators Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].

   

1-O-(3-Hydroxybutyryl)pancratistatin

1-O-(3-Hydroxybutyryl)pancratistatin

C18H21NO10 (411.1165406)


   

3,7,8-tris(4-Hydroxyphenyl)-pyrrolo[2,1-c][1,4]oxazin-1-one

3,7,8-tris(4-Hydroxyphenyl)-pyrrolo[2,1-c][1,4]oxazin-1-one

C25H17NO5 (411.1106672)


   

4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, hydrogen sulfate (ester), (3S-trans)-Pheno

4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, hydrogen sulfate (ester), (3S-trans)-Pheno

C19H22FNO6S (411.11518040000004)


   

N-(4-acetylphenyl)-4-hydroxy-N-[(4-methoxyphenyl)methyl]benzenesulfonamide

N-(4-acetylphenyl)-4-hydroxy-N-[(4-methoxyphenyl)methyl]benzenesulfonamide

C22H21NO5S (411.1140376000001)


   

2,3,5-TRI-O-ACETYL-8-FLUORO ADENOSINE

2,3,5-TRI-O-ACETYL-8-FLUORO ADENOSINE

C16H18FN5O7 (411.11902100000003)


   
   

ZM 323881 HCl

ZM 323881 hydrochloride

C22H19ClFN3O2 (411.11497560000004)


   

O-benzyl-L-methionine toluene-p-sulphonate

O-benzyl-L-methionine toluene-p-sulphonate

C19H25NO5S2 (411.117408)


   
   

4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile

4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile

C18H16F3N3O5 (411.10420020000004)


   

2-methyl-3-{4-[4-(trifluoromethoxy)phenoxy]phenyl}quinolin-4(1H)-one

2-methyl-3-{4-[4-(trifluoromethoxy)phenoxy]phenyl}quinolin-4(1H)-one

C23H16F3NO3 (411.1082222)


   

3-[6,6-dimethyl-3-(methylthio)-4-oxo-5,7-dihydro-2-benzothiophen-1-yl]-N-phenyl-1-pyrazolecarboxamide

3-[6,6-dimethyl-3-(methylthio)-4-oxo-5,7-dihydro-2-benzothiophen-1-yl]-N-phenyl-1-pyrazolecarboxamide

C21H21N3O2S2 (411.1075126)


   

N-(1,3-benzothiazol-2-yl)-2-(3-methoxyphenyl)-4-quinolinecarboxamide

N-(1,3-benzothiazol-2-yl)-2-(3-methoxyphenyl)-4-quinolinecarboxamide

C24H17N3O2S (411.1041422)


   

2-(4-bromophenyl)-1-(4-ethoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

2-(4-bromophenyl)-1-(4-ethoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

C22H24BrN2O+ (411.1071894)


   

VU6019650

VU6019650

C18H22FN3O3S2 (411.10865540000003)


VU6019650 is a potent and selective orthosteric antagonist of M5 mAChR (IC50=36 nM), can be used for opioid use disorder (OUD) relief. VU6019650 can cross blood brain barrier, potentially modulates the mesolimbic dopaminergic reward circuitry. VU6019650 blocks Oxotremorine M iodide (HY-101372A) induced increases of neuronal firing rates of midbrain dopamine neurons in the ventral tegmental area (VTA)[1][2].

   

2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl 3-hydroxybutanoate

2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl 3-hydroxybutanoate

C18H21NO10 (411.1165406)


   

(1r,2r,3s,4s,4ar,11br)-2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl (3s)-3-hydroxybutanoate

(1r,2r,3s,4s,4ar,11br)-2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl (3s)-3-hydroxybutanoate

C18H21NO10 (411.1165406)